Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Silvia Zibellini"'
Autor:
Daniele Vanni, Oscar Borsani, Yasuhito Nannya, Emanuela Sant'Antonio, Chiara Trotti, Ilaria Carola Casetti, Daniela Pietra, Anna Gallì, Silvia Zibellini, Virginia Valeria Ferretti, Luca Malcovati, Seishi Ogawa, Luca Arcaini, Elisa Rumi
Publikováno v:
eJHaem, Vol 3, Iss 2, Pp 475-479 (2022)
Abstract In a cohort of 3131 patients with myeloproliferative neoplasms (MPNs), we identified 200 patients (6.4%) who reported a second case of haematological malignancies (HM) in first‐ or second‐degree relatives. The occurrence of a second HM i
Externí odkaz:
https://doaj.org/article/57d48c417fe9467db435b7e339e51b40
Autor:
Gabriele Merati, Marianna Rossi, Anna Gallì, Elisa Roncoroni, Silvia Zibellini, Ettore Rizzo, Daniela Pietra, Cristina Picone, Barbara Rocca, Claudia Patricia Tobar Cabrera, Eleonora Gelli, Eugenio Santacroce, Luca Arcaini, Patrizia Zappasodi
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Acute leukemia of ambiguous lineage (ALAL) is a rare type of leukemia and represents an unmet clinical need. In fact, due to heterogeneity, substantial rarity and absence of clinical trials, there are no therapeutic guidelines available. We investiga
Externí odkaz:
https://doaj.org/article/eab51768fab14e468d4f14307f1fa62d
Autor:
Martina Ferrante, Daniela Furlan, Silvia Zibellini, Michela Borriero, Chiara Candido, Nora Sahnane, Silvia Uccella, Elisa Genuardi, Beatrice Alessandria, Benedetta Bianchi, Barbara Mora, Daniele Grimaldi, Irene Defrancesco, Cristina Jiménez, Federica Cavallo, Dario Ferrero, Irene Dogliotti, Michele Merli, Marzia Varettoni, Simone Ferrero, Daniela Drandi
Publikováno v:
Diagnostics, Vol 11, Iss 5, p 779 (2021)
In IgM monoclonal gammopathies MYD88L265P is a prognostic and predictive biomarker of therapy response. MYD88L265P detection is mainly performed by allele-specific quantitative PCR (ASqPCR), however recently, droplet digital PCR (ddPCR) has been prov
Externí odkaz:
https://doaj.org/article/371db568c5794271940665ed00da127b
Autor:
Marzia Varettoni, Silvia Zibellini, Irene Defrancesco, Virginia Valeria Ferretti, Ettore Rizzo, Luca Malcovati, Anna Gallì, Matteo Giovanni Della Porta, Emanuela Boveri, Luca Arcaini, Chiara Candido, Marco Paulli, Mario Cazzola
Publikováno v:
Haematologica, Vol 102, Iss 12 (2017)
We analyzed MYD88 and CXCR4 mutation status of 260 patients with Waldenström macroglobulinemia or IgM monoclonal gammopathy of undetermined significance using allele-specific real time quantitative polymerase chain reaction and Sanger sequencing, re
Externí odkaz:
https://doaj.org/article/167287e719e040a3a76b1cdb3c418f3e
Publikováno v:
Leukemia Research Reports, Vol 4, Iss 2, Pp 45-46 (2015)
Primary resistance to tyrosine-kinase inhibitors (TKIs) is quite uncommon in chronic-phase Chronic Myeloid Leukemia (CML) and related to still poorly understood mechanisms, as ABL mutations are rarely detected in primary resistant patients. We report
Externí odkaz:
https://doaj.org/article/7af4202a8b1e4fa1ab2e25b7452015ac
Autor:
Enrico Tiacci, Gianluca Schiavoni, Maria Paola Martelli, Emanuela Boveri, Roberta Pacini, Alessia Tabarrini, Silvia Zibellini, Alessia Santi, Valentina Pettirossi, Elisabetta Fortini, Stefano Ascani, Luca Arcaini, Giorgio Inghirami, Marco Paulli, Brunangelo Falini
Publikováno v:
Haematologica, Vol 98, Iss 4 (2013)
The BRAF-V600E mutation defines genetically hairy cell leukemia among B-cell leukemias and lymphomas. In solid tumors, BRAF-V600E is known to aberrantly activate the oncogenic MEK-ERK pathway, and targeted BRAF and/or MEK inhibitors have shown remark
Externí odkaz:
https://doaj.org/article/dd19befec6bc4ec6b4818304288543d6
Autor:
Elisa Rumi, Francesco Passamonti, Chiara Elena, Daniela Pietra, Luca Arcaini, Cesare Astori, Silvia Zibellini, Emanuela Boveri, Cristiana Pascutto, Mario Lazzarino
Publikováno v:
Haematologica, Vol 96, Iss 3 (2011)
Within a cohort of 1,915 consecutive patients with myeloproliferative neoplasm followed for a median time of 5.2 years (range 0–33.3), we investigated the occurrence of lymphoid neoplasm with the aim of defining this risk and to investigate the rol
Externí odkaz:
https://doaj.org/article/5164001a56bb4a5aa66caed651fccd5f
Autor:
Silvia Zibellini, Daniela Capello, Francesco Forconi, Paolo Marcatili, Davide Rossi, Sara Rattotti, Silvia Franceschetti, Elisa Sozzi, Emanuele Cencini, Roberto Marasca, Luca Baldini, Alessandra Tucci, Francesco Bertoni, Francesco Passamonti, Ester Orlandi, Marzia Varettoni, Michele Merli, Silvia Rizzi, Valter Gattei, Anna Tramontano, Marco Paulli, Gianluca Gaidano, Luca Arcaini
Publikováno v:
Haematologica, Vol 95, Iss 10 (2010)
Antigen stimulation may be important for splenic marginal zone lymphoma pathogenesis. To address this hypothesis, the occurrence of stereotyped B-cell receptors was investigated in 133 SMZL (26 HCV+) compared with 4,414 HCDR3 sequences from public da
Externí odkaz:
https://doaj.org/article/25ccbb9a7f66499d99c8cd5ad4089647
Autor:
Laura Gragnani, Serena Lorini, Silvia Marri, Sara Rattotti, Francesco Madia, Silvia Zibellini, Monica Monti, Umberto Basile, Enrico Di Stasio, Massimo Libra, Luca Arcaini, Anna Linda Zignego
Publikováno v:
Hematological Oncology. 40:658-666
Cryoglobulinemic Vasculitis (CV) is an autoimmune/lymphoproliferative disorder associated with HCV infection that in 5%-10% of cases evolves into a B cell Non-Hodgkin's Lymphoma (NHL). B-cell activating factor (BAFF) is a key regulator in B-cell deve
Autor:
Marianna Rossi, Maria Elena Nizzoli, Anna Gallì, Elisa Roncoroni, Silvia Zibellini, Gabriele Merati, Ettore Rizzo, Barbara Rocca, Daniela Pietra, Cristina Picone, Marco Brociner, Claudia Patricia Tobar Cabrera, Eleonora Gelli, Eugenio Santacroce, Luca Arcaini, Patrizia Zappasodi
Publikováno v:
American Journal of Hematology. 97